This study consisted of the design and conduct of a multifaceted midstream evaluation of the overall portfolio of comparative effectiveness research (CER) funded by Congress in the American Recovery and Reinvestment Act (ARRA). The evaluation aimed to characterize the projects, and identify early lessons learned from the projects and their implications for future HHS CER investments. It did not assess the findings and outcomes of individual projects as most of the projects were still ongoing at the time of the evaluation.
Almost half of all projects funded by ARRA CER had a primary emphasis on research, with the majority focused on generating new evidence that could improve the delivery of healthcare. Twenty-seven percent of the funds were invested in data infrastructure projects and capacity building necessary for conducting rigorous CER. Investment in projects related to human and scientific capital which focused on career development and methods work accounted for 15 percent of the funds. Thirteen percent of the funds were invested in dissemination and translation work focused on the ways in which CER findings can be implemented into practice to impact patient care. The study identified early lessons, including those focused on multi-institutional research collaborations and CER data infrastructure projects.
Report Title: Health Care Quality and Outcomes (CER Research)
Agency Sponsor: OASPE, Office of the Assistant Secretary for Planning and Evaluation
Federal Contact: Pierre Yong, 202-690-8384
Performer: Mathematica Policy Research
Record ID: 9759 (December 31, 2012)